Newly formulated GROWJECT® is bioequivalent to the prior GROWJECT® formulation and causes less injection-associated pain

Clinical Pediatric Endocrinology ◽

10.1297/cpe.30.35 ◽

2021 ◽

Vol 30 (1) ◽

pp. 35-40

Author(s):

Yasuko Owada ◽

Yuuka Asano ◽

Takashi Hanada ◽

Hidehito Yasukawa ◽

Mariko Yamaoka ◽

...

Download Full-text